BRUSSELS, BELGIUM / RankWire.AI / – The European Commission has enhanced its efforts to combat the Ebola outbreak by allocating €2.1 million for the procurement of PCR tests targeting the Bundibugyo virus. This initiative involves open-platform testing kits that laboratories can utilize with their existing equipment. The procurement process received support from the European Health and Digital Executive Agency. Shipping is expected to commence in August as health teams respond to a significant outbreak centered in the Democratic Republic of the Congo and impacting surrounding regions.
The World Health Organization will facilitate the distribution of these tests through its Hub for Global Health Emergencies Logistics based in Dubai. WHO will oversee the allocation to various locations actively involved in the Ebola response. PCR testing enables laboratories to verify infections and bolster surveillance efforts around confirmed cases. Health teams rely on these validated results to direct patient treatment, enforce isolation protocols, and trace contacts. This latest supply package strengthens laboratory capabilities amid ongoing monitoring of transmission across multiple provinces and health zones in the Democratic Republic of the Congo.
Previously, the European Commission arranged an additional €2.5 million package that includes rapid molecular point-of-care tests and testing devices. These will support the Africa Centres for Disease Control and Prevention in their regional response activities. Together, the diagnostic agreements amount to a total of €4.6 million. These initiatives are part of a broader European support package aimed at assisting countries confronting the Bundibugyo Ebola crisis. This aid encompasses medical supplies, preparedness efforts, and public health resources designed to strengthen the response in affected and neighboring areas.
Testing capabilities expand amid a major outbreak
According to WHO figures, the Democratic Republic of the Congo had recorded 4,665 confirmed cases and 2,184 deaths as of August 12. The outbreak has been identified across 54 health zones in six provinces, including Ituri, North Kivu, South Kivu, Haut-Uélé, Tshopo, and Bas-Uélé. WHO has described this as the largest Ebola outbreak documented within the country. The organization also highlighted ongoing transmission within connected geographic clusters, which continues to place considerable demands on surveillance teams, laboratories, treatment centers, and local health services.
In its August update, WHO maintained a very high national risk assessment for the Democratic Republic of the Congo. It also classified the risk for neighboring countries as high, while the risk elsewhere remained low. Following a meeting of its International Health Regulations Emergency Committee on August 24, WHO issued updated temporary recommendations. These guidelines address issues such as surveillance, case detection, infection prevention, clinical management, and community engagement. They also include measures related to mobility and large gatherings during the ongoing response efforts.
European health aid totals €493 million
The European Commission announced that it has mobilized €493 million to support emergency aid, vaccines, treatments, and health security initiatives across the Great Lakes and Uganda regions. European health agencies have contributed to laboratory operations, surveillance, and preparedness activities as well. The European Centre for Disease Prevention and Control continues to rate the risk to populations in Europe as very low. Since Ebola mainly spreads through direct contact with infected bodily fluids, rapid detection, safe clinical practices, and effective infection control are critical to limiting further transmission.
The Bundibugyo virus outbreak remains a public health emergency of international concern under WHO’s international health framework. Currently, no approved vaccine or specific treatment exists for Bundibugyo virus disease. Consequently, health authorities continue to depend on surveillance, rapid diagnostics, isolation, clinical management, infection control, and close contact monitoring. The newly acquired PCR testing capacity enhances this response. WHO, Africa CDC, and national health agencies continue their coordinated efforts as countries work to identify cases swiftly and uphold public health measures within affected communities.